Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal CancerScott Kopetz, Josep Tabernero, Fotios Loupakis et al.|New England Journal of Medicine|2019Cited by 1.5k
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Johann S. de Bono, Adam Sharp et al.|Nature|2023Cited by 119
Characterizing CDK12-Mutated Prostate CancersPasquale Rescigno, Johann S. de Bono, Bora Gürel et al.|Clinical Cancer Research|2020Cited by 100
B7-H3 as a Therapeutic Target in Advanced Prostate CancerChristina Guo, Johann S. de Bono, Ines Figueiredo et al.|European Urology|2022Cited by 90